Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
Pakistan
· Delayed Price · Currency is PKR 919.98
+0.44 (0.05%)
At close: Apr 28, 2026
PSX:ABOT Revenue
Abbott Laboratories (Pakistan) had revenue of 17.70B PKR in the quarter ending March 31, 2026, with 2.07% growth. This brings the company's revenue in the last twelve months to 75.76B, up 9.01% year-over-year. In the year 2025, Abbott Laboratories (Pakistan) had annual revenue of 75.40B with 10.59% growth.
Revenue (ttm)
75.76B
Revenue Growth
+9.01%
P/S Ratio
1.19
Revenue / Employee
54.90M
Employees
1,380
Market Cap
90.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.40B | 7.22B | 10.59% |
| Dec 31, 2024 | 68.18B | 12.70B | 22.90% |
| Dec 31, 2023 | 55.48B | 6.22B | 12.62% |
| Dec 31, 2022 | 49.26B | 6.69B | 15.71% |
| Dec 31, 2021 | 42.57B | 7.29B | 20.65% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 65.90B |
| The Searle Company | 33.26B |
| AGP Limited | 28.89B |
| Highnoon Laboratories | 27.71B |
| Citi Pharma | 14.10B |
| Ferozsons Laboratories | 22.22B |
| Macter International | 11.95B |
| Otsuka Pakistan | 4.15B |